The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D012107:Research Design; D013197:Stanozolol / Q000008:administration & dosage / Q000627:therapeutic use*; D000979:alpha-2-Antiplasmin / Q000032:analysis
D000979:alpha-2-Antiplasmin; D013197:Stanozolol; D005340:Fibrinogen; D010958:Plasminogen